prefilled semaglutide syringe GLP-1 Therapy for Obesity Requires Substantial Nutritional Framework, Multidisciplinary Support, Joint Advisory Warns and reduced FDA alerts health care providers,

Protein Tyrosine Tyrosine, PYY PYY is produced by, and secreted from, intestinal enteroendocrine L-cells of the ileum and colon

GLP-1 potentiates glucose-induced insulin secretion, inhibits glucagon secretion but also has extrapancreatic effects and inhibits appetite and food intake

Low-grade inflammation, obesity, and insulin resistance in adolescents

If you meet the eligibility criteria and have a BMI 30 or a BMI 27 with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol, you may qualify for a prescription

PlexusDx providers can discuss structured meal plans and behavioral supports to prevent rapid weight regain after semaglutide discontinuation